Range
- - -
Vol / Avg.
-/68.3K
Div / Yield
-
52 Wk
0.02 - 0.08
Mkt Cap
30.9M
Payout Ratio
-
Open
-
P/E
-
Shares
1.3B
Outstanding
-
Total Float
-
Zelira Therapeutics Ltd is a biotechnology company focused on developing a range of cannabinoid-based formulations for the treatment of various medical conditions in Australia. The company is involved in a human clinical trial program focused on insomnia, autism, and eczema; and a pre-clinical research program to examine the effect of cannabinoids in breast, brain, and pancreatic cancer.

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target

Zelira Therapeutics Questions & Anwsers

Q

How do I buy Zelira Therapeutics (ZLDAF) stock?

A

You can purchase shares of Zelira Therapeutics (OTCQB: ZLDAF) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Zelira Therapeutics's (ZLDAF) competitors?

A

There are no as such competitors for Zelira Therapeutics.

Q

What is the target price for Zelira Therapeutics (ZLDAF) stock?

A

There is no analysis for Zelira Therapeutics

Q

Current Stock Price for Zelira Therapeutics (ZLDAF)?

A

The stock price for Zelira Therapeutics (OTCQB: ZLDAF) is $0.0242 last updated Tue Dec 07 2021 18:00:53 GMT+0000 (Coordinated Universal Time).

Q

Does Zelira Therapeutics (ZLDAF) pay a dividend?

A

There are no upcoming dividends for Zelira Therapeutics.

Q

When is Zelira Therapeutics (OTCQB:ZLDAF) reporting earnings?

A

Zelira Therapeutics does not have any upcoming earnings scheduled.

Q

Is Zelira Therapeutics (ZLDAF) going to split?

A

There is no upcoming split for Zelira Therapeutics.

Q

What sector and industry does Zelira Therapeutics (ZLDAF) operate in?

A

Zelira Therapeutics is in the sector and industry. They are listed on the OTCQB.